-
Overview
-
Assays
-
Case Study
-
Experience
-
Instruments and Software
-
FAQs
-
Related Resources
-
Related Services
Overview
MetID team utilizes ultra-high performance liquid chromatography (UPLC) coupled with a photodiode array detector (PDA) and high-resolution mass spectrometry (HRMS) to search for and identify the metabolites generated in incubation systems, which can provide three types of routine assays based on different purposes, including metabolic soft-spot analysis, reactive metabolite trapping and cross-species metabolism comparison. Meanwhile, the team can provide some special types of assays or methods, such as acidified S9/lysosomal systems used for antibody drug conjugates (ADCs), metabolite matching, hydrogen/deuterium (H/D) exchange and titanium trichloride reduction assays used to confirm the metabolite structure.
Learn More
Assays
Case Study
-
Metabolite Profiling and Identification of Compound A (Commercially Available) in Rat, Dog, Monkey, and Human Hepatocytes
A total of eight metabolites (M1-M8) were detected and identified by LC-UV-HRMS after incubated in rat, dog, monkey, and human hepatocytes for 120 minutes. The LC-UV (λ: 270-360 nm) chromatograms and the relative abundance of compound A and its metabolites were summarized in Figure 1 and Table 1, respectively.
Compared with animal species, the metabolites formed in incubation of human hepatocytes were detected in hepatocytes of at least two animal species. In human hepatocytes, M1, M6 and M8 were considered to be the top three metabolites, while the relative abundance of M6 in all animal species was less than 1% which may due to further glucuronidation of M6. By comprehensive comparison with animal species, the metabolite profiling of compound A in human hepatocytes was similar to that in dog hepatocytes. Considering the similarity of metabolism in vitro, dog is a suitable large animal species for toxicological evaluation of compound A.
Learn More
-
Metabolite profiles (LC-UV) of Compound A in rat, dog, monkey, and human hepatocytes
Figure 1
-
The relative abundance of compound A and its metabolites in rat, dog, monkey, and human hepatocytes
Table 1
-
Experience
-
16+
Years of experience
-
500+
Submissions of IND applications
-
8000+
Screening projects
Instruments and Software
-
Instruments
-
Software
-
-
Thermo Orbitrap Eclipse™ Tribrid™
-
Thermo Orbitrap Exploris™ 480
-
Thermo Q-Exactive™ HF
-
Waters VION™ IMS QTof
-
Thermo Q-Exactive™ Plus
-
Thermo Q-Exactive™
-
Therno LTQ Orbitrap XL
-
Waters Xevo®G2 QTof
-
Solid scintillation counter: off-line detection of radioactivity
-
Liquid scintillation counter: total radioactivity detection
-
On-line detection of radioactivity
-
-
-
Thermo Scientific™ Compound Discoverer™
-
Thermo Scientific™ Mass Frontier™
-
Thermo Scientific™ Metworks™
-
Waters MetaboLynxTM
-
Mass Analytical Mass-MetaSite
-
Waters UNIFI®
-
Thermo Scientific™ Biopharma Finder™
-
FAQs
-
How is in vitro metabolite profiling and identification performed?
Based on the purpose of the experiment, appropriate metabolic systems (liver microsomes, hepatocytes and plasma, etc.) and incubation conditions (incubation time, substrate concentration, enzyme concentration and so on) were selected for incubation. After incubation, samples would be extracted by suitable pre-treatment methods such as protein precipitation, liquid-liquid extraction, solid phase extraction and so on, then analyzed by LC-UV-HRMS.
Metabolites will be screened by the comparison with the blank control samples, the structures of the metabolites and metabolic pathway would be proposed based on the interpretation of their MS and MS2 data and fragmentation pattern of test article, combined with diverse data processing software, multiple data processing techniques and professional judgment of the researchers.
-
What analytical techniques are used in in vitro metabolite profiling and identification?
In vitro MetID utilizes ultra-high performance liquid chromatography (UPLC) coupled with a photodiode array detector (PDA) and high-resolution mass spectrometry (HRMS) for data acquisition, and combined with data processing software (Xcalibur, Compound Discoverer, Masslynx, Mass Metasite, etc.) and multiple data processing techniques (mass deficit filtering, background deduction, characteristic ion extraction, and isotope filtering, etc.) to search for and to identify metabolites.
-
When conducting an in vitro MetID study, how to determine incubation conditions such as incubation time and matrices?
When conducting in vitro MetID study, the incubation time and incubation matrixes will be adjusted based on the purpose of the experiment and the in vitro stability of the test compound in the incubation medium. For example, when performing a metabolic soft spot analysis, long incubation time is not recommended, generally 1-2 half-life are suitable. When conducting in vitro MetID study of slow metabolic compounds in hepatocytes, adherent cells or relay method would be suitable for incubation.
-
Based on the results of in vitro MetID study, which metabolites should be focused on?
Metabolites which are only found in human or have significantly higher proportion in human than other species or have potential toxicity (e.g. glucuronidation metabolites) require extra attention.
Related Resources
-
Prodrug Approaches for Improved DMPK Characteristics and Their Preclinical Study Considerations
ArticlesAug 29, 2024Learn More -
Development of a Convenient In Vitro Method for Predicting Metabolism and Disposition of Acrylamide Covalent Drugs in Humans
PostersMar 21, 2024Learn More -
Effect of pH on Metabolite Profiling and Identification of GalNAc Conjugated siRNA in In Vitro Metabolic System
PostersJan 23, 2024Learn More -
Metabolite Profiling and Identification of Oligonucleotide in In Vitro Metabolic System
PostersOct 30, 2023Learn More
Stay Connected
Keep up with the latest news and insights.